Cargando…

Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2

CONTEXT: Suchilactone, a lignan compound extracted from Monsonia angustifolia E.Mey. ex A.Rich. (Geraniaceae), has little research on pharmacological activity; whether suchilactone has inhibitory effect on acute myeloid leukaemia (AML) is unclear. OBJECTIVE: To investigate the antitumor effect of su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jingjing, Deng, Yuan, Zhang, Xin, Ma, Jingjing, Zheng, Xinqi, Chen, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725822/ https://www.ncbi.nlm.nih.gov/pubmed/34962431 http://dx.doi.org/10.1080/13880209.2021.2017467

Ejemplares similares

Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
por: Meng, Guangqiang, et al.
Publicado: (2023)

SHP1 and SHP2 inhibition enhances the pro-differentiative effect of phorbol esters: an alternative approach against acute myeloid leukemia
por: Pérez-Fernández, Alejandro, et al.
Publicado: (2019)

Acute Myeloid Leukaemia in Its Niche: the Bone Marrow Microenvironment in Acute Myeloid Leukaemia
por: Ladikou, E. E., et al.
Publicado: (2020)

A Novel Fatty Acid Metabolism-Associated Risk Model for Prognosis Prediction in Acute Myeloid Leukaemia
por: Wang, Nana, et al.
Publicado: (2023)

Targeting apoptosis in acute myeloid leukaemia
por: Cassier, Philippe A, et al.
Publicado: (2017)

Adhesion Deregulation in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukaemia
por: Almosailleakh, Marwa, et al.
Publicado: (2019)

Wnt Signalling in Acute Myeloid Leukaemia
por: Gruszka, Alicja M., et al.
Publicado: (2019)

Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2021)

IL-8 as mediator in the microenvironment-leukaemia network in acute myeloid leukaemia
por: Kuett, Alexander, et al.
Publicado: (2015)

PHF6 mutation is associated with poor outcome in acute myeloid leukaemia
por: Huang, Kexiu, et al.
Publicado: (2022)

Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcoma
por: Waselewski, Alexander, et al.
Publicado: (2018)

Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived mice.
por: Franks, C. R., et al.
Publicado: (1977)

Proceedings: Active immunotherapy in acute myeloid leukaemia.
por: Freeman, C. B., et al.
Publicado: (1975)

Rarity of microsatellite alterations in acute myeloid leukaemia.
por: Sill, H., et al.
Publicado: (1996)

Acute Myeloid Leukaemia Presenting as Gaze Palsy
por: Sykakis, Evripidis, et al.
Publicado: (2011)

'Lot's Wife' Syndrome in Acute Myeloid Leukaemia
por: Barnett, M. M.
Publicado: (1984)

Acute Myeloid Leukaemia: New Targets and Therapies
por: Brown, Geoffrey, et al.
Publicado: (2017)

Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
por: Khan, Ghazala Naz, et al.
Publicado: (2019)

Prognostic Parameters of Acute Myeloid Leukaemia at Presentation
por: Jahic, Azra, et al.
Publicado: (2017)

Targeting Apoptotic Pathways in Acute Myeloid Leukaemia
por: Sillar, Jonathan R., et al.
Publicado: (2019)

Combined inhibition of XIAP and autophagy induces apoptosis and differentiation in acute myeloid leukaemia
por: Huang, Ziyang, et al.
Publicado: (2023)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Prognostic significance of KMT2A-PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysis
por: Ye, Wu, et al.
Publicado: (2023)

Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018)

Chemotherapy of the Myeloid Leukaemias
por: Stuart, John
Publicado: (1980)

The clinical and prognostic significance of FOXN3 downregulation in acute myeloid leukaemia
por: Zhang, Jinjing, et al.
Publicado: (2020)

The E3 ubiquitin ligase WWP1 sustains the growth of acute myeloid leukaemia
por: Sanarico, A G, et al.
Publicado: (2018)

A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia
por: Zhu, Jiewen, et al.
Publicado: (2013)

Sidestepping SHP2 inhibition
por: Popescu, Bogdan, et al.
Publicado: (2023)

Matrine induces Akt/mTOR signalling inhibition‐mediated autophagy and apoptosis in acute myeloid leukaemia cells
por: Wu, Junqing, et al.
Publicado: (2016)

Inactivation of the tyrosine phosphatase SHP-2 drives vascular dysfunction in Sepsis
por: Heun, Yvonn, et al.
Publicado: (2019)

Immunotherapy of acute myeloid leukaemia. Medical Research Council.
Publicado: (1978)

Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups
por: Moorman, A V, et al.
Publicado: (2002)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

The rocky road to personalized medicine in acute myeloid leukaemia
por: Brinda, Bryan, et al.
Publicado: (2018)

N6-Methyladenosine Role in Acute Myeloid Leukaemia
por: Ianniello, Zaira, et al.
Publicado: (2018)

Prediction of acute myeloid leukaemia risk in healthy individuals
por: Abelson, Sagi, et al.
Publicado: (2018)

SRC-Family Kinases in Acute Myeloid Leukaemia and Mastocytosis
por: Voisset, Edwige, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3lecjh69b99b02dms2os94smga